spyretx.com - Spyre Therapeutics

Description: Engineering For New Heights in the Treatment of Inflammatory Bowel Disease

ulcerative colitis (143) ibd (138) monoclonal antibodies (58) inflammatory bowel disease (54) mabs (32) crohn’s disease (31) α4β7 (26) tl1a (26) il-23 (26) uc/cd (26)

Example domain paragraphs

Spyre Therapeutics Acquired by Aeglea BioTherapeutics | Read ⁠More

TRANSFORMING THE TREATMENT OF INFLAMMATORY BOWEL DISEASE Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.

LinkedIn Twitter Engineering for new heights in the treatment of Inflammatory Bowel Disease Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches with the goal of creating Inflammatory Bowel Disease (IBD) therapies with uncompromising efficacy and convenience.

Links to spyretx.com (3)